To whom it may concern, Due to unprecedented increases in the costs of raw materials, logistics/freight, energy, and labor, Halocarbon Life Sciences, LLC will be
January 7, 2022 Dechra is pleased to announce the acquisition of the veterinary approved Isoflurane®, USP Inhalant Anesthetic and Sevoflurane®, USP Inhalant Anesthetic from Halocarbon.
Dear Valued Customer, Due to significant increases in the cost of our raw materials, labor costs, and freight/logistics costs, Halocarbon Life Sciences, LLC will be
Peptide synthesis and solid-phase synthesis remain fundamental processes in the development of today’s most advanced pharmaceutical applications. For over 30 years, Halocarbon has been a
Sevoflurane was first discovered as an inhalation anesthetic in the early 1970s. Since its clinical introduction in the 1990s, Sevoflurane has become the leading and
Halocarbon has Built a Legacy of Innovation in Anesthesia Halocarbon is a company built on firsts. As one of the world’s leading producers in specialty
(470) 419-6364
[email protected]
6525 The Corners Parkway, Suite 200 Peachtree Corners, GA 30092
1100 Dittman Ct North Augusta, SC 29841
Please let us know how we can help you by filling out the form below and clicking submit. Our helpful staff will contact you in a timely manner.
© 2025 Halocarbon Life Sciences, LLC Halocarbon©, the Halocarbon logo, and the Let’s create your next BreakthroughTM tagline are registered trademarks of Halocarbon. All rights reserved. Website By Conceptdigital
